FICKENSCHER JAMES E (Chief Financial Officer) sold 10.3% of their position (17.77K shares) of ZYNERBA PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $10.6K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 1/25/2023ACC: 0001062993-23-001386
Officer· Chief Financial Officer
Since Aug 2018
+152.23K
Net shares
Net buyer
$10.6K
Total sold
1
Open market trades
0B · 1S
2
Total transactions
170K acquired · 17.77K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−17.77K
Price / share
$0.60
Trade value
$10.62K
% of position
10.3%
1/23/2023
172.50K→154.74K
Common Stock
Direct
Shares
+170K
Price / share
—
Trade value
—
% of position
109.9%
1/24/2023
154.74K→324.74K
Total
Net shares
+152.23K
Net value
-$10.62K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/23/2023 | S · Sale | −17.77K | $0.60 | $10.62K | 10.3% | 172.50K | 154.74K |
| Common Stock Direct | 1/24/2023 | A · Award | +170K | — | — | 109.9% | 154.74K | 324.74K |
| Total | +152.23K | -$10.62K | ||||||
Derivative Transactions0
No derivative transactions reported